JESSICA MADOW: Open Payments
NPI 1992339626 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 68 payments from 16 companies in 2025. Trend: 2023 $3,616 · 2024 $4,064 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $295 |
| ABBVIE INC. | 8 | $268 |
| PFIZER INC. | 15 | $201 |
| CATALYST PHARMACEUTICALS, INC. | 5 | $120 |
| ACADIA Pharmaceuticals Inc | 4 | $85 |
| Neurelis, Inc. | 4 | $74 |
| Lilly USA, LLC | 4 | $67 |
| LivaNova USA, Inc. | 3 | $65 |
| SK Life Science, Inc. | 2 | $61 |
| JAZZ PHARMACEUTICALS INC. | 2 | $54 |
Products named: NURTEC ODT, EPKINLY, FYCOMPA, Briviact, Fintepla, Nayzilam, VALTOCO, Leqembi.
Industry payments across NY — which companies pay providers there.
